Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Trial of Leflunomide in Patients With High-Risk Smoldering Multiple Myeloma

NCT04370483 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT04370483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04370483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Trial of Leflunomide in Patients With High-Risk Smoldering Multiple Myeloma
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
October 8, 2020
Completion date
November 10, 2026
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoldering plasma cell myeloma